José María L. P.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Debio 0123 Combined with Carboplatin and Etoposide in Adults with Recurrent or Progressive Small Cell Lung Cancer Post-Platinum Therapy
- Phase I Clinical Trial of TOS-358 in Adult Patients with Advanced Solid Tumors: Colorectal, Cervical, Endometrial, Gastric, Urothelial, Breast, Head and Neck, Ovarian, and NSCLC.
- Phase 1 Study of AMX-818 Monotherapy and Combination with Pembrolizumab in Advanced or Metastatic HER2-Expressing Cancers
Data & Insights
Has run more than one trial at 78 of 159 partner sites.
Specializations
Head and Neck Cancer Research
The investigator specializes in treating head and neck squamous cell carcinoma (HNSCC), with particular focus on recurrent and metastatic disease. Their research encompasses both first-line treatments and therapeutic approaches for previously treated patients.
- PD-L1 positive HNSCC
- Metastatic disease management
- Immunotherapy combinations
Lung Cancer Studies
Demonstrates extensive involvement in both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) research, focusing on advanced and metastatic disease states.
- Advanced NSCLC treatment
- Recurrent SCLC therapy
- Novel combination approaches
Advanced Solid Tumors
Conducts research across multiple solid tumor types, with special attention to HER2-expressing cancers and novel therapeutic strategies.
- Gastrointestinal cancers
- Gynecologic malignancies
- HER2-positive tumors
- Immunotherapy development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.